A Pilot Study of Lenalidomide Maintenance Therapy in Stage IIIB/IV Non-small Cell Lung Cancer After First-line Chemotherapy
Phase of Trial: Phase I
Latest Information Update: 19 Jan 2018
Price : $35 *
At a glance
- Drugs Lenalidomide (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 16 Jan 2018 Status changed from active, no longer recruiting to discontinued.
- 11 Apr 2016 Status changed from recruiting to active, no longer recruiting.
- 14 Jul 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.